scispace - formally typeset
L

Linnea Zimmerman

Researcher at Johns Hopkins University

Publications -  63
Citations -  717

Linnea Zimmerman is an academic researcher from Johns Hopkins University. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 11, co-authored 34 publications receiving 334 citations.

Papers
More filters
Journal ArticleDOI

PMA2020: Rapid Turn-Around Survey Data to Monitor Family Planning Service and Practice in Ten Countries.

TL;DR: Performance Monitoring and Accountability 2020 (PMA2020) was created to provide rapid and frequent estimates of modern contraceptive use in FP2020 priority countries to monitor country progress and change course in the event of stagnating or declining use.
Journal ArticleDOI

Measuring family planning quality and its link with contraceptive use in public facilities in Burkina Faso, Ethiopia, Kenya and Uganda.

TL;DR: The results suggest that service quality in public facilities may be less relevant to contraceptive use in environments where the universe and reach of providers changes actively, and programs promoting contraception need to consider quality within facility types and their service environments.
Journal ArticleDOI

Need for and use of contraception by women before and during COVID-19 in four sub-Saharan African geographies: results from population-based national or regional cohort surveys.

TL;DR: The findings do not support the anticipated deleterious effect of COVID-19 on access to and use of contraceptive services by women in the earliest stages of the pandemic, and overall trends mask several distinct patterns by sociodemographic group.
Journal ArticleDOI

Contraceptive dynamics during COVID-19 in sub-Saharan Africa: longitudinal evidence from Burkina Faso and Kenya.

TL;DR: In this article, the authors used longitudinal data collected from women at risk of unintended pregnancy in Burkina Faso and Kenya before (November 2019-February 2020) and during (May-July 2020) COVID-19 to quantify contraceptive dynamics during COVID, and assess COVID19-related reasons for contraceptive non-use.
Journal ArticleDOI

Mortality risks in children aged 5–14 years in low-income and middle-income countries: a systematic empirical analysis

TL;DR: Empirical analysis suggests that mortality risks nowadays in the age range 5-14 years in low-income and middle-income countries are rather higher (relative to mortality in children younger than 5 years) than would be expected on the basis of historical evidence.